These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9177418)
21. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis. Colpan L; Gur A; Cevik R; Nas K; Sarac AJ Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968 [TBL] [Abstract][Full Text] [Related]
22. Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy? Kotaniemi A; Piirainen H; Paimela L; Leirisalo-Repo M; Uoti-Reilama K; Lahdentausta P; Ruotsalainen P; Kataja M; Väisänen E; Kurki P J Rheumatol; 1996 Nov; 23(11):1875-9. PubMed ID: 8923359 [TBL] [Abstract][Full Text] [Related]
23. A rat model of thyroid hormone-induced bone loss: effect of antiresorptive agents on regional bone density and osteocalcin gene expression. Kung AW; Ng F Thyroid; 1994; 4(1):93-8. PubMed ID: 8054866 [TBL] [Abstract][Full Text] [Related]
24. Markers of bone turnover in hyperthyroidism and the effects of treatment. Garnero P; Vassy V; Bertholin A; Riou JP; Delmas PD J Clin Endocrinol Metab; 1994 Apr; 78(4):955-9. PubMed ID: 8157727 [TBL] [Abstract][Full Text] [Related]
25. Effect of calcitonin on bone and connective tissue metabolism in hemiplegic patients: a two-year prospective study. Uebelhart D; Hartmann DJ; Barbezat S; Mermillod B; Chantraine A Clin Rehabil; 1999 Oct; 13(5):384-91. PubMed ID: 10498345 [TBL] [Abstract][Full Text] [Related]
26. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease. Lucidarme N; Ruiz JC; Czernichow P; Léger J J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822 [TBL] [Abstract][Full Text] [Related]
27. Intranasal calcitonin suppresses increased bone resorption during short-term immobilization: a double-blind study of the effects of intranasal calcitonin on biochemical parameters of bone turnover. van der Wiel HE; Lips P; Nauta J; Kwakkel G; Hazenberg G; Netelenbos JC; van der Vijgh WJ J Bone Miner Res; 1993 Dec; 8(12):1459-65. PubMed ID: 8304047 [TBL] [Abstract][Full Text] [Related]
28. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391 [TBL] [Abstract][Full Text] [Related]
29. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study. Lange U; Teichmann J; Müller-Ladner U; Strunk J Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785 [TBL] [Abstract][Full Text] [Related]
30. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men. Guven Z; Karadag-Saygi E; Unlu-Ozkan F; Akyuz G Aging Male; 2007 Dec; 10(4):197-201. PubMed ID: 18033629 [TBL] [Abstract][Full Text] [Related]
31. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626 [TBL] [Abstract][Full Text] [Related]
33. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception. Young NR; Baker HW; Liu G; Seeman E J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450 [TBL] [Abstract][Full Text] [Related]
34. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment. Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179 [TBL] [Abstract][Full Text] [Related]
35. [Evaluation of bone mineral density in hyperthyroid patients before and after medical therapy]. Safi S; Hassikou H; Hadri L; Sbihi A; Kadiri A Ann Endocrinol (Paris); 2006 Mar; 67(1):27-31. PubMed ID: 16596054 [TBL] [Abstract][Full Text] [Related]
36. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine. Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602 [TBL] [Abstract][Full Text] [Related]
37. Corticosteroid-induced bone loss in men. Pearce G; Tabensky DA; Delmas PD; Baker HW; Seeman E J Clin Endocrinol Metab; 1998 Mar; 83(3):801-6. PubMed ID: 9506731 [TBL] [Abstract][Full Text] [Related]
38. Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women. Mango D; Ricci S; Manna P; Natili G; Dell'Acqua S Minerva Endocrinol; 1993 Sep; 18(3):115-21. PubMed ID: 8183178 [TBL] [Abstract][Full Text] [Related]
39. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ; J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495 [TBL] [Abstract][Full Text] [Related]
40. [Changes of bone and mineral metabolism in patients with hyperthyroidism before and after treatment]. Chai R; Ye Z; Zhan Z Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):682-4. PubMed ID: 11038794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]